Life Sciences Conferences

The Burrill Personalized Medicine Meeting

Day One
7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 9:30 a.m.
Welcome and Personalized Medicine Industry Update
G. Steven Burrill, CEO, Burrill & Company

9:30 – 9:45 a.m.
Break

9:45 – 10:30 a.m.
Keynote Presentation: Omics – Genomics/ Proteomics/ Metabolomics…where is science taking us?
George Poste, DVM, PhD, Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor and Del E. Webb Chair in Health Innovation, Arizona State University

10:30 – 11:30 a.m.
First Generation PM Companies – Where are they now? What can we learn?
Panelists:
David Levison, President & CEO, CardioDx
Matthew Meyer, Chief Business Officer, XDx
Brian Ward, CEO, diaDexus
David Brunel, CEO, Biodesix
Moderator: Sean X. Hu, PhD, MBA, Head, Bionest USA & Managing Partner, North America, BIONEST Partners

11:30 a.m. – 12:30 p.m.
‘Conversations with Experts’ Luncheon
Sponsored by: Kelly Services

12:30 – 2:00 p.m.
Company Presentations:
Michael Sherman, CFO, Endocyte
Clifford Reid, CEO, Complete Genomics
Christopher Garabedian , CEO President & Director, Sarepta
Thomas H. Tulip, Chief Business Officer and Exec. VP, Navidea
Introduced by: Elemer Piros, Senior Research Analyst, Burrill & Company

2:00 – 3:00 p.m.
We’re long on data, short on actionable information – Can we create value?
Panelists:
Scott Kahn, Chief Information Officer, Illumina
David Daly, VP of Oncology, Life Technologies
Ashley Ledbetter Dombkowski, PhD, Chief Business Officer, 23andMe
Mark Dente, Chief Medical Officer, Healthcare Information Technology, GE Healthcare
Kris Joshi, Global Vice President Healthcare, Oracle
Moderator: David Wetherell, President and Chief Operating Officer, Burrill Healthcare Venture and Private Equity Funds, Burrill & Company

3:00 – 3:30 p.m.
Break

3:30 – 4:30 p.m.
How do we utilize advocacy organizations to further Personalized Medicine?
Panelists:
Edward Abrahams, President, PM Coalition
Andrew Fish, Executive Director, AdvaMedDx
Marcia K. Horn, President and CEO, ICAN
Moderator: G. Steven Burrill, CEO, Burrill & Company 

4:30 – 5:30 p.m.
Transforming Educated Guesses to Tailor Made Treatments - Bringing Together the Players
Panelists:
Thomas H. Tulip, PhD, Chief Business Officer & Executive VP, Navidea
Christopher Garabedian , CEO President & Director, Sarepta
Clifford Reid, CEO, Complete Genomics
Michael Sherman, CFO, Endocyte
Moderator: Reni Benjamin, Senior Research Analyst, Burrill & Company 

5:30 p.m.
Meeting Wrap-Up (Day One)
G. Steven Burrill, CEO, Burrill & Company

5:30 – 7:00 p.m.
Networking Reception
Sponsored By: BIOQUEST

Day Two

7:30 – 8:30 a.m.
Breakfast

8:30 – 9:30 a.m.
Keynote Presentation: Topic TBD
George Church, Professor of Genetics, Harvard Medical School, Director of PersonalGenomes.org
Introduced by: G. Steven Burrill, CEO, Burrill & Company

9:30 – 10:30 a.m.
Personalized Medicine from a Drug Developer’s Point of View
Panelists:
Edward Abrahams, President, PM Coalition
Pauline Farmer-Koppenol, Associate, Fenwick & West
Gwendolyn A. Fyfe, Former VP BioOncology, Genentech
Neil Warma, President & CEO, Opexa Therapeutics, Inc.
Moderator: Jason Zhang, Senior Research Analyst, Burrill & Company 

10:30 – 10:45 a.m.
Break

10:45 – 11:45 a.m.
What will the next generation of PM Companies look like?
Panelists:
Ralph Snyderman, Chancellor Emeritus, Duke University
Zachary D. Hornby, VP, Corporate Development, NexDx, Inc. 
Kenneth Fang, Chief Medical Officer, VP, Translational Research & Clinical Development, Integrated Diagnostics
Moderator: Elemer Piros, Senior Research Analyst, Burrill & Company  

11:45 a.m.
Meeting Wrap-Up
G. Steven Burrill, CEO, Burrill & Company

12:00 p.m.
Lunch